Skip to main content
MANIFOLD
Will human-generated cells (e.g SpudCells) be able to independently produce ribosomes by EOY 2035?
1
Ṁ1kṀ576
2035
29%
chance

Resolution criteria

This market will resolve to YES if, by December 31, 2035 (EOY 2035), a peer-reviewed scientific study or a widely accepted announcement from a major research institution establishes that human-generated, bottom-up synthetic cells (such as "SpudCells" or subsequent chassis built from nonliving chemical components) are capable of independently synthesizing their own functional ribosomes.

To satisfy "independently produce ribosomes," the synthetic cells must:

  1. Contain the necessary genetic templates and biochemical pathways to transcribe ribosomal RNA (rRNA) and translate ribosomal proteins entirely in vivo (within the synthetic cell).

  2. Successfully assemble these components into functional, active ribosomes capable of driving protein translation.

  3. Sustain multiple generations of growth and protein synthesis without relying on the external introduction of pre-assembled, functional ribosomes (e.g., via specialized broth, feeder liposomes, or direct injection) once the lineage is initiated.

If, by December 31, 2035, synthetic cells still require pre-fabricated ribosomes supplied from external sources to maintain protein synthesis and replicate, this market will resolve to NO.

The market creator will resolve this based on scientific publications in reputable journals (such as Nature, Science, or equivalent peer-reviewed biological sciences publications) or consensus reporting by major science news outlets (such as Science News or Nature News).

Background

In July 2026, researchers publicly announced the creation of "SpudCells"—the first synthetic cells constructed entirely from nonliving chemical components ("bottom-up") that are capable of growth, nutrient intake, and division. While a major breakthrough for synthetic biology, SpudCells are not fully autonomous. A primary limitation is that they cannot build their own protein-making machinery. Instead, they must absorb pre-fabricated ribosomes from their surrounding liquid or feeder liposomes to make proteins. Because these imported ribosomes eventually degrade, the cell lines conk out and fail to sustain themselves beyond five to ten generations. A major goal for synthetic biology institutions, such as the newly formed Biotic, is to engineer synthetic cells capable of autonomous ribosome assembly, which would represent a critical milestone toward truly self-sustaining artificial life.

Resolution criteria

This market will resolve to YES if, by December 31, 2035 (EOY 2035), a peer-reviewed scientific study or a widely accepted announcement from a major research institution establishes that human-generated, bottom-up synthetic cells (such as "SpudCells" or subsequent chassis built entirely from nonliving chemical components) are capable of independently synthesizing their own functional ribosomes.

To satisfy the requirement to "independently produce ribosomes," the synthetic cells must:

  • Contain the necessary genetic templates and biochemical pathways to transcribe ribosomal RNA (rRNA) and translate ribosomal proteins entirely in vivo (within the synthetic cell).

  • Successfully assemble these components into functional, active ribosomes capable of driving protein translation.

  • Sustain multiple generations of growth and protein synthesis without relying on the external introduction of pre-assembled, functional ribosomes (e.g., via specialized broth, feeder liposomes, or direct injection) once the lineage is initiated.

If, by December 31, 2035, synthetic cells still require pre-fabricated ribosomes supplied from external sources to maintain protein synthesis and replicate, this market will resolve to NO.

The market creator will resolve this based on scientific publications in reputable journals (such as Nature, Science, or equivalent peer-reviewed biological sciences publications) or consensus reporting by major science news outlets (such as Science News or Nature News).

Background

In July 2026, researchers at the University of Minnesota announced the creation of "SpudCells"—the first synthetic cells constructed entirely from nonliving chemical components ("bottom-up") capable of nutrient intake, growth, and division. While a major breakthrough for synthetic biology, SpudCells are not fully autonomous.

A primary limitation is that they cannot build their own protein-making machinery. Instead, they must absorb pre-fabricated ribosomes (such as those from E. coli) from feeder liposomes in their surrounding liquid to make proteins. Because these imported ribosomes eventually degrade, the cell lines fail to sustain themselves beyond approximately five to ten generations.

Engineering synthetic cells capable of autonomous ribosome assembly is a primary goal for synthetic biology research groups and the newly formed nonprofit "Biotic". Overcoming this bottleneck would represent a critical milestone toward truly self-sustaining artificial life.

Market context
Get
Ṁ1,000
to start trading!